Literature DB >> 12609703

Molecular pathogenesis of bilateral breast cancer.

Evgeny N Imyanitov1, Kaido P Hanson.   

Abstract

Bilateral breast cancer (biBC) offers intriguing possibilities for molecular genetic investigations, however it is disproportionally less studied than its unilateral counterpart. By now, genetic research has succeeded to resolve at least two important aspects of biBC pathogenesis. First, it has been confirmed, that the vast majority if not all biBC arise due to clonally independent events but not due to contralateral metastatic spread. Second, unselected biBC cases have been shown to have a modest prevalence of BRCA germ-line mutations (approximately 5%), although a considerable frequency of BRCA defects (up to 20%) has been observed in early-onset and/or familial forms of the disease. Other data related to biBC appear to be at suggestive stage. Recent reports demonstrate, that the tumors forming biBC pair may show similarities of their molecular portraits, especially if they develop synchronously. This observations imply that the host factors may determine not only the level of breast cancer susceptibility, but also the molecular variant of the disease development. Apart from this, biBC may serve as a very demonstrative case group in the studies of breast cancer predisposing low-penetrance gene polymorphisms, because it is more likely to accumulate unfavorable allele combinations than the unilateral patients. The utility of this approach has been already exemplified by several scientific publications. Further research on the biBC molecular pathogenesis may significantly contribute to the general understanding of the process of malignant transformation.

Entities:  

Mesh:

Year:  2003        PMID: 12609703     DOI: 10.1016/s0304-3835(02)00523-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

Review 1.  Cancer stem cells: a novel paradigm for cancer prevention and treatment.

Authors:  Dharmalingam Subramaniam; Satish Ramalingam; Courtney W Houchen; Shrikant Anant
Journal:  Mini Rev Med Chem       Date:  2010-05       Impact factor: 3.862

2.  Microsatellite instability analysis of bilateral breast tumors suggests treatment-related origin of some contralateral malignancies.

Authors:  Ekatherina Sh Kuligina; Maxim Yu Grigoriev; Evgeny N Suspitsin; Konstantin G Buslov; Olga A Zaitseva; Olga S Yatsuk; Yulia R Lazareva; Alexandr V Togo; Evgeny N Imyanitov
Journal:  J Cancer Res Clin Oncol       Date:  2006-08-10       Impact factor: 4.553

3.  Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer.

Authors:  Catherine Schairer; Linda M Brown; Phuong L Mai
Journal:  Breast Cancer Res Treat       Date:  2011-03-09       Impact factor: 4.872

4.  Long-term survival of screen-detected synchronous and metachronous bilateral non-palpable breast cancer among Chinese women: a hospital-based study (2003-2017).

Authors:  Bo Pan; Ying Xu; Yidong Zhou; Ru Yao; Xingtong Zhou; Yali Xu; Xinyu Ren; Mengsu Xiao; Qingli Zhu; Lingyan Kong; Feng Mao; Yan Lin; Xiaohui Zhang; Songjie Shen; Qiang Sun
Journal:  Breast Cancer Res Treat       Date:  2022-09-27       Impact factor: 4.624

5.  Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer.

Authors:  Ava Kwong; L P Wong; H N Wong; F B F Law; E K O Ng; Y H Tang; W K Chan; D T K Suen; C Choi; L S Ho; K H Kwan; M Poon; T T Wong; K Chan; S W W Chan; M W L Ying; W C Chan; E S K Ma; J M Ford; D W West
Journal:  Hugo J       Date:  2010-04-10

6.  Reducing Disparities in Receipt of Genetic Counseling for Underserved Women at Risk of Hereditary Breast and Ovarian Cancer.

Authors:  Arnethea L Sutton; Alejandra Hurtado-de-Mendoza; John Quillin; Lisa Rubinsak; Sarah M Temkin; Tamas Gal; Vanessa B Sheppard
Journal:  J Womens Health (Larchmt)       Date:  2019-11-27       Impact factor: 2.681

7.  Prediction of outcome after diagnosis of metachronous contralateral breast cancer.

Authors:  Sara Alkner; Pär-Ola Bendahl; Mårten Fernö; Jonas Manjer; Lisa Rydén
Journal:  BMC Cancer       Date:  2011-03-30       Impact factor: 4.430

8.  The prognostic comparison among unilateral, bilateral, synchronous bilateral, and metachronous bilateral breast cancer: A meta-analysis of studies from recent decade (2008-2018).

Authors:  Bo Pan; Ying Xu; Yi-Dong Zhou; Ru Yao; Huan-Wen Wu; Qing-Li Zhu; Chang-Jun Wang; Feng Mao; Yan Lin; Song-Jie Shen; Qiang Sun
Journal:  Cancer Med       Date:  2019-04-30       Impact factor: 4.452

9.  Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing.

Authors:  Sara Alkner; Man-Hung Eric Tang; Christian Brueffer; Malin Dahlgren; Yilun Chen; Eleonor Olsson; Christof Winter; Sara Baker; Anna Ehinger; Lisa Rydén; Lao H Saal; Mårten Fernö; Sofia K Gruvberger-Saal
Journal:  Breast Cancer Res       Date:  2015-08-05       Impact factor: 6.466

10.  Assessment of DNA methylation profiling and copy number variation as indications of clonal relationship in ipsilateral and contralateral breast cancers to distinguish recurrent breast cancer from a second primary tumour.

Authors:  Katie T Huang; Thomas Mikeska; Jason Li; Elena A Takano; Ewan K A Millar; Peter H Graham; Samantha E Boyle; Ian G Campbell; Terence P Speed; Alexander Dobrovic; Stephen B Fox
Journal:  BMC Cancer       Date:  2015-10-09       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.